Previous Article | Next Article ![]()
Journal of Virology, January 2002, p. 178-184, Vol. 76, No. 1
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.76.1.178-184.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Laboratory of Virology, Wageningen University and Research Center, 6709 PD Wageningen, The Netherlands,1 Joint Laboratory of Invertebrate Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Peoples Republic of China2
Received 19 July 2001/ Accepted 26 September 2001
|
|
|---|
|
|
|---|
Recently, a novel type of envelope fusion (F) protein was identified in BVs of group II NPVs, notably in SeMNPV (22) and LdMNPV (37). For SeMNPV this F protein is encoded by ORF8 (Se8) (21). A C-terminal 60-kDa subunit of the 76-kDa primary translation product was found to be the major envelope protein of SeMNPV BV. Several protein bands with molecular sizes in the 15- to 17-kDa range were found (22), and one of these could represent the N-terminal subunit of the F protein. The involvement of furin in the cleavage was hypothesized on the basis of the presence of furin-like proprotein convertase site RSKR immediately upstream of the N terminus of the 60-kDa cleavage product (22).
Cleavage of viral fusion proteins seems to be a general mechanism to activate these proteins and to produce infectious viruses. The cleavage takes place in front of a hydrophobic sequence, the "fusion peptide." Exposure to low pH or receptor binding triggers a conformational change whereby the fusion peptide is believed to translocate to the top of the molecule and to insert into the target membrane (25). A number of fusion proteins of vertebrate viruses are cleaved by furin. These include human cytomegalovirus glycoprotein B (50), human parainfluenza virus type 3 F (36), Ebola virus glycoprotein GP (52), and avian influenza virus hemagglutinin (HA) (47). The furin-mediated cleavage yields in all these cases two subunits that are disulfide linked. Furin is localized in the trans-Golgi network (51) and cleaves after the consensus cleavage site R-X-R/K-R (20, 32). The arginine immediately upstream of the cleavage site is the most essential amino acid (32). For Ebola virus envelope protein GP it has been shown that changing this arginine into a lysine results in an uncleaved precursor protein (52). Cleavage of some fusion proteins can be inhibited by peptidyl-chloroalkylketones containing the R-X-K/R-R motif, which specifically bind to the catalytic site of furin (10, 15, 40, 47).
In this paper evidence is provided by using a furin inhibitor and mutational analysis of the furin-like proprotein convertase site that cleavage of the SeMNPV BV F protein is mediated by furin and that this cleavage is required to activate the SeMNPV F protein to render infectious BVs. Furthermore, whether both subunits of the primary translation product are present in the SeMNPV BV and whether these remain associated to each other are investigated.
|
|
|---|
Plasmid constructions.
The regions coding for amino acids 1 (M) to 149 (R) (F2) and amino acids 150 (G) to 579 (G) (F1
580-665) of ORF8 in the SeMNPV genome were amplified by high-fidelity Expand long-template PCR (Boehringer Mannheim) from plasmid pSeBglII-H (21). Primers used to amplify F1
580-665 were 5'-TTTGGATCCCGGCCTTTTTAATTTTATGG-3' (underlined nucleotides generated a BamHI site) and 5'-AATAAGCT TAACCGATGCTGGAAAACCACGAAGAC-3' (underlined and boldface nucleotides generated a HindIII site and a translation stop codon, respectively). Primers used for amplifying F2 were 5'-TTGGGATCCTATGCTGCGTTTTAAAGTGATTGTG-3' (underlined nucleotides generated a BamHI site) and 5'-ATTAAGCTTAGCGTTTAGAGCGTCTTTTCGTCG-3' (underlined and boldface nucleotides generated a HindIII site and a translation stop codon, respectively). The PCR products were cloned into the BamHI and HindIII cloning sites of expression vector pET28a (Novagen) to generate pET28-SeF1
580-665 and pET28-SeF2.
PCR-based site-directed mutation of the arginine (R149) immediately upstream of the convertase cleavage site into a lysine (K149) was performed according to the method of Sharrocks and Shaw (43). The 5' primer 5'-TTATGGATCCATGCTGCGTTTTAAAGTGATTGTG-3' and the 3' mutagenic primer 5'-CCCATAAAATTAAAAAGGCCCTTTTTAGAGCGTCTTTTCGTCG-3' (underlined nucleotides generated the mutation) were used in conjunction with plasmid p166AcV5-Se8 (22) as a template to introduce the R149-to-K149 mutation using high-fidelity Expand long-template PCR (Boehringer Mannheim). The PCR product was agarose gel purified, and the single strand containing the mutation at the 3' end served as a 5' mutagenic primer in a second PCR together with 3' primer 5'-GAGAGGCACGGGCCACGAAAGG-3'. The second PCR product was cloned into pGEM-T (Promega) to generate pGEM-Se8(K149). Plasmids p166AcV5-Se8(K149) and p166AcV5-Se8(K149)GFP were obtained by exchanging the BamHI/StuI fragment of pGEM-Se8(K149) with those of p166AcV5-Se8 and p166AcV5-Se8GFP (22), respectively.
Production of polyclonal antibodies.
Proteins F1
580-665 and F2 were expressed in Escherichia coli Bl21 cells containing vector pET28-SeF1
580-676 or pET2-SeF2 and were purified as described previously (23). The proteins were concentrated using a Centriprep 10-kDa filter device (Amicon) and dialyzed against phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). Protein concentrations were determined with the Bio-Rad protein assay.
Two chickens were injected intramuscularly with either 200 µg of purified F1
580-665 or F2 protein using a water-in-oil adjuvant. The chickens were boosted after 4 weeks with 150 µg of purified protein. Two weeks after the booster, eggs were collected every day for 2 weeks. The egg yolk was diluted threefold (wt/wt) in PBS containing 5.25% polyethylene glycol 6000 (PEG-6000) and 0.05% NaN3. The mixture was centrifuged for 15 min at 2,250 x g. The supernatant was filtered through glass wool, and PEG-6000 was added until 12% (wt/vol) was reached. After centrifugation for 15 min at 2,250 x g, the pellet was dissolved in water and centrifuged as before to remove debris. PEG-6000 was added to the solution until 12% (wt/vol) was reached, and centrifugation for 20 min at 2,250 x g was performed. The pellet containing polyclonal antibodies against fusion protein subunit F1 (
-F1) or F2 (
-F2) was dissolved in 2.5 ml of 0.9% NaCl per egg and stored at -20°C.
Purification of SeMNPV BV and ODV. Hemolymph-derived BVs were purified from SeMNPV-infected S. exigua fourth-instar larvae as described previously (22) with some modifications. Briefly, 3 days postinfection (p.i.) hemolymph was collected and clarified at 2,000 x g for 10 min at 4°C. The supernatant was passed through a 0.45-µm-pore-size filter. BVs in the filtrate were pelleted through a 25% (wt/wt) sucrose cushion made up in 0.1x TE (10 mM Tris-HCl [pH 7.5], 1.0 mM EDTA) by centrifugation at 100,000 x g for 90 min at 4°C and resuspended in 0.1x TE. BVs from cell culture supernatants were purified in a similar fashion. Se301 cells were infected with 0.1 50% tissue culture infective dose (TCID50) of SeMNPV/cell. Seventy-two hours p.i. cell culture supernatants were clarified at 2,000 x g for 10 min at 4°C and passed through a 0.45-µm-pore-size filter. BVs in the filtrate were pelleted and resuspended as described above. ODVs were purified from polyhedra derived from SeMNPV-infected S. exigua fourth-instar larvae as described previously (22). The purity and integrity of BVs and ODVs were checked by electron microscopy.
Western blot analysis. For electrophoresis under reducing conditions purified SeMNPV ODVs and BVs were disrupted in Laemmli buffer (125 mM Tris-HCl, 2% sodium dodecyl sulfate [SDS], 5% 2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue, pH 6.8). For electrophoresis under nonreducing conditions virions were disrupted in 125 mM Tris-HCl-8% SDS-37.5 mM iodoacetamide-10% glycerol-0.001% bromophenol blue, pH 6.8. Samples were denatured for 10 min at 95°C. Proteins were electrophoresed in SDS-polyacrylamide gels and transferred onto Immobilon-P membranes (Millipore) by semidry electrophoresis transfer (2). Membranes were blocked overnight at 4°C in PBS containing 2% milk powder, followed by incubation for 1 h at room temperature (RT) with antiserum at a dilution of 1:1,000 in PBS containing 0.2% milk power. After being washed three times for 15 min in PBS-T (PBS containing 0.1% Tween 20), the membranes were incubated for 1 h at RT with horseradish peroxidase conjugated with rabbit anti-chicken immunoglubulin (Sigma) diluted 1:50,000 in PBS containing 0.2% milk powder. After three washes for 15 min in PBS-T, the signal was detected by ECL technology as described by the manufacturer (Amersham).
Furin inhibition assay. Se301 cells (2.0 x 105) were infected with 10 TCID50s of SeMNPV or AcMNPV/cell. At 2 h p.i. cells were washed twice with medium and incubated with medium containing a 50 µM concentration of furin cleavage inhibitor decanoylated arginyl-valyl-lysyl-arginyl chloromethylketone (dec-RVKR-cmk) (Bachem). The AcMNPV-infected cells were incubated without dec-RVKR-cmk. Cell culture supernatants were collected at 48 h p.i, and infectious BV was quantified by a TCID50 assay (35) on Se301 cells. The SeMNPV-infected cells were washed three times with medium without FBS and assayed for the presence of active fusion proteins in the plasma membrane by a syncytium formation assay as described below.
Syncytium formation assay. Syncytium formation assays were performed by transfection of 5.0 x 105 Sf21 cells with 5 µg of DNA of p166AcV5-Se8 or p166AcV5-Se8(K149) using CellFECTIN (Gibco-BRL). Empty vector p166BRNX-AcV5 (22) was used as a negative control for the syncytium formation assay. Forty-eight hours after transfection, cells were washed three times with medium without FBS and treated for 2 min in acidic medium without FBS, pH 5.0. The acidic medium was replaced with medium with FBS, pH 6.1. Syncytium formation was recorded by light microscopy 4 h after treatment with the acidic medium. Syncytium formation was positive when at least four nuclei were present in each syncytial mass.
Fluorescence microscopy. To investigate the cellular location of the mutant SeMNPV F protein, 1.0 x 105 Sf21 cells were grown on glass coverslips and transfected with 5 µg of DNA of p166AcV5-Se8GFP or p166AcV5-Se8(K149)GFP. As a control for green fluorescent protein (GFP), expression plasmid p166AcV5-GFP (22) was used. At 48 h posttransfection the localization of GFP in the cells was examined with a Zeiss LSM510 (confocal) laser scanning microscope for fluorescence using an excitation wavelength of 488 nm and an emission bandpass filter of 505 to 530 nm.
Computer-assisted analysis. The SeMNPV F protein was analyzed for several protein motifs using different bioinformation programs. N-terminal signal sequences were found with program PSORT II (National Institute for Basic Biology [http://www.nibb.ac.jp]). Possible coiled-coil regions in the protein were predicted using the program PairCoil (version 1.0; MIT Laboratory for Computer Science [http://www.lcs.mit.edu]). Comparisons between the SeMNPV F protein and other viral fusion proteins were done with program FASTA (version 3; EMBL-European Bioinformatics Institute [http://www.ebi.ac.uk]). Sequence alignments were performed with program ClustalW (EMBL-European Bioinformatics Institute [http://www.ebi.ac.uk]).
|
|
|---|
Supernatants of SeMNPV-infected Se301 cells (48 h p.i.), grown in the presence or absence of dec-RVKR-cmk (50 µM), were assayed for the amount of infectious progeny BV by determining TCID50s. In the presence of the furin inhibitor the virus titer was reduced dramatically to 2% of the titer for the control (absence of the inhibitor) (Fig. 1, lanes 1 and 2). This drop could be caused by either distortion in the BV assembly pathway, giving no new progeny BVs, or by progeny BVs that are not infectious anymore due to the presence of uncleaved fusion proteins (F0) in their envelopes. In a similar experiment with AcMNPV the furin inhibitor had no effect on the virus titer (Fig. 1, lanes 3 and 4), indicating that the furin inhibitor did not affect the formation of BV per se.
![]() View larger version (29K): [in a new window] |
FIG. 1. Effect of furin inhibitor dec-RVKR-cmk on SeMNPV and AcMNPV BV infectivity. Se301 cells were infected with SeMNPV (lanes 1 and 2) or AcMNPV (lanes 3 and 4) in the presence (lanes 2 and 4) or absence (lanes 1 and 3) of furin inhibitor dec-RVKR-cmk. At 48 h p.i. the titer of progeny infectious BV in the cell culture supernatants was determined by TCID50 assays. The data presented are means and standard deviations of three independent experiments.
|
-F1) revealed the presence of a 60-kDa protein (F1) in both BV preparations (Fig. 2, lanes 1 and 2). BV obtained from cell cultures incubated in the presence of the furin inhibitor possessed an additional 80-kDa protein (F0) (Fig. 2, lane 2). These experiments showed that blocking the furin-mediated cleavage of F0 did not impair the assembly of BVs.
![]() View larger version (24K): [in a new window] |
FIG. 2. Western blot analysis of proteins obtained from SeMNPV BV, produced in the absence (-; lane 1) or presence (+ lane 2) of furin inhibitor dec-RVKR-cmk. BVs were incubated for 10 min at 95°C in Laemmli buffer and subjected to SDS-PAGE (12% polyacrylamide). Proteins were transferred onto an Immobilon-P membrane (Millipore), incubated with -F1, and detected with a chemiluminescent substrate. Size standards in kilodaltons are on the left. F0, precursor SeMNPV F protein; F1, 60-kDa subunit of SeMNPV F protein.
|
![]() View larger version (57K): [in a new window] |
FIG. 3. SeMNPV-mediated fusion of Se301 cells. Cells were infected with SeMNPV in the absence (A) or presence (B) of furin inhibitor dec-RVKR-cmk. Forty-eight hours p.i. cells were incubated for 2 min with medium, pH 5.0. Syncytium formation was scored 4 h after dropping the pH by phase-contrast microscopy.
|
![]() View larger version (70K): [in a new window] |
FIG. 4. Localization studies with SeMNPV wild-type F and mutant FK149-GFP fusion proteins (A to C) and their ability to mediate cell-to-cell fusion in Sf21 cells (D to F). For the localization studies, Sf21 cells were transfected with plasmid p166AcV5-Se8GFP (A), p166AcV5-Se8(K149)GFP (B), or control plasmid p166AcV5-GFP (C). Fluorescence was examined 48 h after transfection by confocal laser scanning microscopy. For pH-dependent membrane fusion, Sf21 cells were transfected with plasmid p166AcV5-Se8 (D), p166AcV5-Se8(K149) (E), or control p166BRNX-AcV5 (F). Forty-eight hours after transfection, cells were treated for 2 min with medium, pH 5.0. Four hours after the pH drop syncytium formation was scored by phase-contrast microscopy.
|
SeMNPV BV contains both F protein subunits. Cleavage of the F0 precursor yields, besides the 60-kDa C-terminal cleavage product (F1), a product of approximately 15 kDa (the N-terminal subunit minus the signal peptide; F2). Several proteins in the 15- to 17-kDa range from BVs purified from hemolymph of SeMNPV-infected S. exigua larvae have been reported (22).
To determine whether SeMNPV BV contains both mature F subunits (F1 and F2) and whether cleavage of the SeMNPV F0 protein occurs in tissue culture as well as in insects, BVs were purified from cell culture supernatants of SeMNPV-infected Se301 cells and from hemolymph obtained from SeMNPV-infected S. exigua larvae. Western analysis with polyclonal antibodies against F1 (
-F1) revealed the presence of a 60-kDa protein in BVs obtained from hemolymph as well as from cell culture (Fig. 5, lanes 1 and 2). Polyclonal antibodies specific against F2 (
-F2) detected a 21-kDa protein in both BV preparations (Fig. 5, lanes 4 and 5). Neither antibodies against F1 nor antibodies against F2 reacted with ODV-derived proteins (Fig. 5, lanes 3 and 6), demonstrating that both F protein subunits are BV specific.
![]() View larger version (57K): [in a new window] |
FIG. 5. Western blot analysis of reduced proteins of SeMNPV virus preparations. Cell culture-derived (CC) BVs, hemolymph-derived (He) BVs, and polyhedra-derived ODVs were incubated for 10 min at 95°C in Laemmli buffer and subjected to SDS-PAGE (12% polyacrylamide). Proteins were transferred onto an Immobilon-P membrane (Millipore), incubated with either -F1 (left) or -F2 (right) antibodies, and detected with a chemiluminescent substrate. Size standards in kilodaltons are on the left. F1, 60-kDa subunit of SeMNPV F protein; F2, 21-kDa subunit of SeMNPV F protein.
|
To determine the type of interaction between F1 and F2, SeMNPV BV proteins were treated with iodoacetamide, which alkylates free sulfhydryl groups and thereby prevents artificial disulfide exchange during further treatment or electrophoresis (14). The proteins were denatured in the absence of reducing agents and electrophoresed in a 12% polyacrylamide gel. Western analysis with
-F1 and
-F2 detected in both cases a single protein with a molecular mass of 80 kDa (F1,2) (Fig. 6A, lanes 1 and 2). The absence of free F1 and F2 indicates that these subunits remain covalently linked after cleavage.
![]() View larger version (46K): [in a new window] |
FIG. 6. Western blot analysis of nonreduced proteins of SeMNPV BV. Cell culture-derived BVs were incubated for 10 min at 95°C in the presence of 37.5 mM iodoacetamide and in the absence of 2-mercaptoethanol and electrophoresed in a 12% (A) or 6% (B) SDS-polyacrylamide gel. Proteins were transferred onto an Immobilon-P membrane (Millipore), incubated with either -F1 or -F2, and detected with a chemiluminescent substrate. Size standards (kilodaltons) are indicated. F1,2, 60- and 21-kDa disulfide-linked subunits of SeMNPV F protein.
|
-F1 and
-F2 detected a major monomeric form of 80 kDa (Fig. 6B, lanes 1 and 2). Antibody
-F2 detected also a possible dimeric form as a minor band of 155 kDa (Fig. 6B, lane 2); higher multimeric forms were not detected. |
|
|---|
In this report it is demonstrated that SeMNPV, a representative of a group II NPV within the Baculoviridae, also expresses its fusion protein as precursor F0. This precursor is posttranslationally cleaved by insect cell furin into two disulfide-linked subunits, F1 and F2, to become active in tissue culture and in insects. The major envelope protein of HaSNPV BV, the product of Ha133, has also been identified and characterized (7; M. Westenberg and H. Z. Wang, personal communication). This protein turned out to be also a C-terminal cleavage product of the SeMNPV F protein homolog. In contrast to the SeMNPV and HaSNPV F proteins, the LdMNPV BV F protein was reported not to be cleaved (37), despite the fact that it possesses a similar furin cleavage site at a position analogous to those in SeMNPV and HaSNPV. An 83-kDa fusion protein was detected in LdMNPV BV purified from cell culture supernatants. Tunicamycin treatment of the cells resulted in an LdMNPV fusion protein with a molecular mass of 72 kDa. The latter value is consistent with a predicted molecular mass of 75 kDa for the product of the whole open reading frame minus the signal sequence (residues 1 to 16). Therefore it is most likely that Ld625Y cells are unable to properly cleave the fusion protein from LdMNPV BV. However the titers of progeny BVs from Ld625Y cells are even higher (41) than that of SeMNPV in Se301 cells. So it is very possible that the activation of the fusion protein of LdMNPV during viral uptake by Ld625Y cells is similar to the activation of the influenza virus A/WSN/33 (H1N1) fusion protein in vertebrate cells. This virus possesses only the uncleaved HA, which is cleaved during uptake presumably by an endosomal protease (6).
The cleavage of the F0 protein by furin was demonstrated by the use of a furin inhibitor at a concentration of 50 µM, which seemed to be the most effective concentration (data not shown). The titers of the progeny BVs produced in the presence of the inhibitor were about 2% of the control titers (Fig. 1). The 2% residual infectious virus is in agreement with similar findings with other viral systems (15, 36, 40) and is probably the result of the instability of the furin inhibitor in aqueous solutions. However, we cannot exclude the possibility that a small proportion of the F0 protein is cleaved by another unknown protease. Infected cells were also unable to form syncytia in the presence of the inhibitor (Fig. 3), which is consistent with earlier reports that cell-to-cell fusion after viral infection could be completely blocked by peptidyl-chloroalkylketones (15, 47). BV assembly was not impaired in the presence of the furin inhibitor (Fig. 2). Nevertheless the amount of F1 protein relative to the amount of F0 protein is not proportional to the drop in virus titer but is in agreement with similar findings for influenza virus, where the cleavage inhibition of HA0 was also not proportional to the drop in hemagglutination titer (47). For influenza viruses and group I NPVs it has been shown that at least three HA trimers (5, 8) and approximately six GP64 trimers (38), respectively, cooperate in the formation of the fusion pore. So, the presence of even small amounts of F0 in BVs can interfere with the mature fusion proteins in the fusion process.
Cleavage products F1 and F2 are covalently associated, similar to the fusion proteins of members of the Orthomomyxoviridae, Herpesviridae, and Paramyxoviridae (28, 29, 42). The F2 subunit of SeMNPV contains only a single cysteine residue (C94), which makes this cysteine the only candidate to form the disulfide bridge with F1. This cysteine residue is conserved among the F protein homologs of HaSNPV (6) and LdMNPV (26). In contrast, the F1 subunit contains 15 cysteine residues. Ten of these are situated upstream of the predicted transmembrane region, and 9 of the 10 are conserved among the group II NPVs (SeMNPV, LdMNPV, HaSNPV). The molecular mass of the F1 subunit (60 kDa) is in close agreement with the molecular mass of 59 kDa predicted from the DNA sequence. The F2 subunit was detected by SDS-PAGE as a 21-kDa peptide (Fig. 5). Upon maturation the F2 subunit might go through some posttranslational modification processes, including N-glycosylation and O-glycosylation (22), which may explain the difference between the theoretical (15 kDa) and actual (21 kDa) sizes of this subunit.
Viral fusion proteins generally form higher-order oligomers (18). In most cases these oligomers are formed by noncovalent interactions. However, envelope fusion protein GP64 of group I NPVs forms a trimer of disulfide-linked monomers (34). The F protein of SeMNPV was predominantly present as a monomer (Fig. 6B). A minor band approximately twice the size of the monomer was also detected. Although this band could represent a dimeric form of the protein, most likely this is due to incomplete denaturation, since this band was only detected by
-F2. Furthermore, treatment of GP64 of AcMNPV under the same conditions resulted in the simultaneous occurrence of trimers together with minor dimers and monomers (data not shown). Therefore, it is concluded that disulfide links are most likely not involved in oligomerization of the F protein. The potential oligomeric structure of the SeMNPV F protein remains to be characterized.
The SeMNPV F protein is very similar in structure to the paramyxovirus fusion protein. Both consist of a small N-terminal subunit linked by a disulfide bridge to the large C-terminal membrane-anchored subunit. The SeMNPV F protein has the highest homology with paramyxovirus human respiratory syncytial virus fusion protein [P03420], with 12% amino acid identity and 36% similarity. Although the overall homology is not high (12%), predicted domains such as
-helices and ß-sheets, as well as the furin cleavage sites, the heptad repeats (HRs), and the transmembrane regions, are structurally conserved. Furthermore, the fusion protein of the paramyxoviruses contains a fusion peptide, which is located at the N terminus of the large membrane-anchored subunit. We predict that the SeMNPV F protein contains a putative fusion peptide at an analogous position. Amino acids 150 to 166 GLFNFMGHVDKYLFGIM contain nine hydrophobic residues (underlined) with hydrophobicity indices (H.I.) higher than 0.62 according to the normalized consensus scale of Eisenberg (9). These hydrophobic residues can be modeled as a hydrophobic face in an
-helix. The average H.I. of the hydrophobic face is 1.1, and the total amino acid stretch has a H.I. of 0.5, which is consistent with those for other viral fusion proteins (55).
The paramyxovirus fusion proteins contain HRs (HR1 and HR2) immediately adjacent to the fusion peptide and the transmembrane domain (27). Previous studies with other viral fusion proteins suggested that these HRs form trimeric hairpin-like structures, with the HR2 regions packing in an antiparallel manner against the inner coiled-coil formed by the HR1 regions. The likely role of the hairpin structure is to facilitate apposition of the viral and cellular membranes by bringing the fusion peptide, which inserts into the cellular membrane, close to the transmembrane segment, which is anchored in the viral membrane (44). The SeMNPV F protein also contains two putative HRs. The first HR is adjacent to the putative fusion peptide and is formed by amino acid residues 174 to 202 (HR1: LhmLantTnsLnsqVkqLndeLivLadyV, where the amino acids in uppercase are the nonpolar, hydrophobic residues). The second putative HR is adjacent to the transmembrane domain and is formed by amino acid residues 521 to 549 (HR2: VddMkinNdlEktnLheLtsrLydLrrrI). Further studies are in progress to confirm whether those motifs indeed are required for the fusion function.
We thank D. Peters for immunization of chickens and providing us with antibody-containing eggs, G. W. Blissard for his advice throughout the research and critical reading of the manuscript, and W. Garten for his advice about the furin inhibitor.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»